Laquinimod
id:
laquinimod-271-13803108
title:
Laquinimod
text:
Laquinimod is an experimental immunomodulator developed by Active Biotech and Teva. It is being investigated as an oral treatment for multiple sclerosis (MS) and Huntington's disease. Laquinimod is the successor of Active Biotech's failed experimental immunomodulator linomide. The compound has been investigated in two Phase II trials using successive magnetic resonance scans (MRI). Laquinimod seems to be able to reduce the MS disease activity on MRI. However, the response to a given dose was dis
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Laquinimod
date created:
date modified:
2024-01-25T10:25:09Z
main entity:
{"identifier":"Q3487584","url":"https://www.wikidata.org/entity/Q3487584"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/5/5d/Laquinimod.svg","width":512,"height":308}
fields total:
13
integrity:
15